~~<i id='54589229FC'><strike id='54589229FC'><tt id='54589229FC'><pre id='54589229FC'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

comprehensive

author：comprehensive 2025-09-06 02:16:30 - browse：297

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.

Diabetes: Better shows data on app’s benefit with GLP-1s

Better Therapeutics announced top-line data suggesting that its prescription app for diabetes treatment, AspyreRx, can boost the impact of GLP-1 diabetes treatments. According to the release, a subgroup analysis of 160 participants in its pivotal trial on GLP-1 treatment found that the behavior modification app produced statistically significant reductions in A1C compared to a control group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Merck to acquire Harpoon Therapeutics for $680 million

focus

Wikipedia

leisure time

explore

hotspot

AdobeIftheCovid-19pandemichasshownusonething,itishowlittlewereallyknowabouthowthehumanimmunesystemwo

WSS

Gene therapy denied for Afghan refugee whose father aided U.S.

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

FDA early review: GLP

Life science postdocs should get big pay hike, NIH panel says

Merck to acquire Harpoon Therapeutics for $680 million

Boston Scientific acquires urology company Axonics for $3.7 billion

entertainment

comprehensive

focus

Drug repurposing or repositioning? The language matters

When women are denied an abortion, their children fare worse than peers

The high cost of giving birth even with insurance

Liquid biopsy for lung cancer is launched by Delfi

Medical leaders decry Supreme Court decision on affirmative action

Gene therapy denied for Afghan refugee whose father aided U.S.

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Merck to acquire Harpoon Therapeutics for $680 million

Anesthesiologist group: stop taking Ozempic before surgery

STAT Virtual Event: JPM Recap, Live!

Wikipedia

Merck to acquire Harpoon Therapeutics for $680 million

Gene therapy denied for Afghan refugee whose father aided U.S.

Study suggests new cause of Down syndrome: cells linked to aging

Stroke deaths set to near 10 million globally by 2050

Fauci's latest grilling in Congress: 9 hours, behind closed doors

FDA rejects Alnylam's heart disease treatment over insufficient data

leisure time

explore

explore

hotspot